Asset Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Asset Management Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Hold	1,756	–	–	0.05%	123
2026 Q1	$296K	Buy	1,756 +4	+0.2%	+$684	0.05%	123
2025 Q4	$296K	Sell	1,752 -2	-0.1%	-$325	0.05%	124
2025 Q3	$253K	Hold	1,754	–	–	0.04%	128
2025 Q2	$222K	Hold	1,754	–	–	0.04%	128
2025 Q1	$224K	Buy	1,754 +1	+0.1%	+$136	0.04%	126
2024 Q4	$232K	Buy	1,753 +1	+0.1%	+$141	0.04%	126
2024 Q3	$255K	Buy	1,752 +1	+0.1%	+$145	0.04%	128
2024 Q2	$240K	Buy	1,751 +3	+0.2%	+$400	0.04%	125
2024 Q1	$240K	Buy	1,748 +1	+0.1%	+$137	0.05%	128
2023 Q4	$237K	Buy	1,747 +2	+0.1%	+$244	0.05%	123
2023 Q3	$213K	Hold	1,745	–	–	0.05%	124
2023 Q2	$222K	Hold	1,745	–	–	0.05%	123
2023 Q1	$225K	Hold	1,745	–	–	0.05%	118
2022 Q4	$229K	Buy	1,745 +3	+0.2%	+$388	0.05%	117
2022 Q3	$204K	Hold	1,742	–	–	0.05%	117
2022 Q2	$205K	Buy	1,742 +1	+0.1%	+$119	0.05%	119
2022 Q1	$227K	Buy	1,741 +1	+0.1%	+$130	0.05%	116
2021 Q4	$266K	Buy	1,740 +2	+0.1%	+$310	0.05%	113
2021 Q3	$281K	Hold	1,738	–	–	0.06%	112
2021 Q2	$285K	Sell	1,738 -102	-6%	-$15.7K	0.06%	114
2021 Q1	$277K	Hold	1,840	–	–	0.06%	111
2020 Q4	$279K	Buy	1,840 +1	+0.1%	+$143	0.07%	101
2020 Q3	$249K	Hold	1,839	–	–	0.07%	104
2020 Q2	$251K	Buy	+1,839	New	+$234K	0.08%	101
2020 Q1	–	Sell	-1,836	Closed	-$221K	–	106
2019 Q4	$221K	Buy	+1,836	New	+$205K	0.07%	109
2019 Q3	–	Sell	-1,899	Closed	-$207K	–	111
2019 Q2	$207K	Buy	1,899 +1	+0.1%	+$106	0.07%	106
2019 Q1	$212K	Buy	+1,898	New	+$208K	0.08%	104
2018 Q4	–	Sell	-1,833	Closed	-$224K	–	104
2018 Q3	$224K	Buy	1,833 +2	+0.1%	+$236	0.08%	103
2018 Q2	$201K	Buy	+1,831	New	+$196K	0.07%	106
2017 Q4	–	Sell	-1,830	Closed	-$203K	–	105
2017 Q3	$203K	Sell	1,830 -300	-14%	-$32.1K	0.08%	101
2017 Q2	$220K	Sell	2,130 -609	-22%	-$60K	0.09%	100
2017 Q1	$268K	Sell	2,739 -15	-0.5%	-$1.44K	0.11%	94
2016 Q4	$244K	Hold	2,754	–	–	0.1%	95
2016 Q3	$266K	Hold	2,754	–	–	0.11%	91
2016 Q2	$236K	Buy	2,754 +3	+0.1%	+$269	0.1%	92
2016 Q1	$239K	Hold	2,751	–	–	0.11%	93
2015 Q4	$310K	Hold	2,751	–	–	0.14%	85
2015 Q3	$278K	Hold	2,751	–	–	0.13%	85
2015 Q2	$338K	Hold	2,751	–	–	0.15%	82
2015 Q1	$315K	Hold	2,751	–	–	0.15%	82
2014 Q4	$278K	Buy	2,751 +3	+0.1%	+$292	0.14%	79
2014 Q3	$251K	Buy	2,748 +3	+0.1%	+$263	0.13%	78
2014 Q2	$235K	Hold	2,745	–	–	0.13%	75
2014 Q1	$216K	Hold	2,745	–	–	0.12%	76
2013 Q4	$208K	Buy	+2,745	New	+$195K	0.13%	76

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Asset Management Group's IBB Position: Q2 2026 in Review

Asset Management Group held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,756 shares worth $334K. The position accounts for 0.05% of the portfolio, ranked #123.

Asset Management Group first reported a position in IBB in Q4 2013 and has held it in 46 quarters since. The position peaked at $338K in Q2 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Asset Management Group held 1,756 shares of iShares Biotechnology ETF worth $334K as of Q2 2026.
Asset Management Group left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.05% of Asset Management Group's portfolio in Q2 2026, its #123 holding.
Asset Management Group first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 46 quarters since.
Asset Management Group's iShares Biotechnology ETF position peaked at $338K in Q2 2015.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Asset Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.